Schwall; Ralph

Patent Applications and Registrations

Patent applications and USPTO patent grants for Schwall; Ralph.The latest application filed is for "methods of treatment using anti-erbb antibody-maytansinoid conjugates".

Company Profile

1.5.13

Schwall; Ralph - Pacifica CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Treatment Using Anti-erbb Antibody-maytansinoid Conjugates App 20200048362 - Blattler; Walter ; et al.	2020-02-13
Methods Of Treatment Using Anti-erbb Antibody Maytansinoid Conjugates App 20170106097 - BLATTLER; Walter ; et al.	2017-04-20
Methods Of Treatment Using Anti-erbb Antibody-maytansinoid Conjugates App 20150110816 - BLATTLER; Walter ; et al.	2015-04-23
Methods Of Treatment Using Anti-erbb Antibody-maytansinoid Conjugates App 20140212411 - BLATTLER; Walter ; et al.	2014-07-31
Methods Of Treatment Using Anti-erbb Antibody-maytansinoid Conjugates App 20130108620 - BLATTLER; Walter ; et al.	2013-05-02
METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES App 20100136033 - Erickson; Sharon ; et al.	2010-06-03
Methods of treatment using anti-ErbB antibody-maytansinoid conjugates Grant 7,575,748 - Erickson , et al. August 18, 2	2009-08-18
Apo-2L receptor agonist and CPT-11 synergism App 20090041788 - Ashkenazi; Avi J. ; et al.	2009-02-12
Methods Of Treatment Using Anti-erbb Antibody-maytansinoid Conjugates App 20080226659 - Erickson; Sharon ; et al.	2008-09-18
APO-2L receptor agonist and CPT-11 synergism App 20070026000 - Ashkenazi; Avi J. ; et al.	2007-02-01
Methods of treatment using anti-ErbB antibody-maytansinoid conjugates Grant 7,097,840 - Erickson , et al. August 29, 2	2006-08-29
Inhibiting HER2 shedding with matrix metalloprotease antagonists App 20060177448 - Carey; Kendall D. ; et al.	2006-08-10
Apo-2L receptor agonist and CPT-11 synergism App 20040228868 - Ashkenazi, Avi J. ; et al.	2004-11-18
Rodent HER2 tumor model Grant 6,632,979 - Erickson , et al. October 14, 2	2003-10-14
HER2-transgenic non-human tumor model App 20020035736 - Erickson, Sharon ; et al.	2002-03-21
Methods of treatment using anti-ErbB antibody-maytansinoid conjugates App 20020001587 - Erickson, Sharon ; et al.	2002-01-03
Protection against liver damage by HGF Grant 5,654,404 - Roos , et al. August 5, 1	1997-08-05
Inhibition of heparin-binding Grant 5,464,815 - Chamow , et al. November 7, 1	1995-11-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.